04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
In the recently decided case of Ford v. Marion County Sheriff’s Office, the United States Court of ...
Read More >
As you no doubt have heard, the United States Department of Labor recently announced changes to fede...
Read More >
Le 25 novembre 2020, la Cour de cassation a opéré un revirement de jurisprudence important pour la p...
Read More >
In 2009, Nevada implemented mandatory safety training for employees performing work on construction ...
Read More >
An agreement to arbitrate sexual harassment claims is enforceable, according to a recent decision ha...
Read More >
Size-of-transaction threshold under Hart-Scott-Rodino Act will increase to $94 million. On February...
Read More >